Application of lignan compound
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HAINAN MEDICAL COLLEGE
- Publication Date
- 2015-11-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biochemical medicine, and in particular relates to the application of a lignan compound. Background technique
[0002] Due to abnormal fat metabolism or operation, one or more lipids in plasma are higher than normal, which is called hyperlipidemia. Lipids that are insoluble or slightly soluble in water must be combined with proteins to exist in the form of lipoproteins. Therefore, hyperlipidemia is often hyperlipoproteinemia. Hyperlipidemia is generally manifested as an increase in plasma cholesterol (TC) or triglyceride (TG) levels or both, which can directly cause some diseases that seriously endanger human health, such as atherosclerosis, coronary heart disease, etc. Cardiovascular disease. At present, the use of lipid-lowering drugs is an effective measure for the prevention and treatment of hyperlipidemia. There are many chemical drugs on the market, including statins, fibrates, etc. Although these chemical...